|
|
|
| home > white papers > Streamlining patient recruitment using EHR data |
|
|
 WHITE PAPERS |
|
|
|
|
Streamlining patient recruitment using EHR data
|
|
The field of (bio)pharmaceutical research is booming. Increasingly more innovative therapeutics are being developed with the ability to drastically improve the quality of life of millions of patients around the world. Rigorously testing each of these candidate drugs for their safety and efficacy is an essential part of the development process. As the number of clinical trials steadily increases, the search for patients who present a specific medical profile and are willing to participate intensifies.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
New Advanced Biological Safety Cabinet Delivers Optimal Sample and User Protection
Watham, MA – (February 24, 2021) – Thermo Fisher Scientific has
further expanded its offering of Class II Biological Safety Cabinets
(BSCs) with the addition of an advanced system, designed to meet the
sample and user protection requirements of bioprocessing, clinical
diagnostic and biopharmaceutical laboratories.
More info >> |
|
 |
White Papers |
 |
|
Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands
West Pharmaceutical Services, Inc.
The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >> |
|
 |
Industry Events |
 |
DIA Europe 2021
15-19 March 2021, VIRTUAL CONFERENCE
DIA Europe is the must-attend event for all life science professionals
working in drug development, from discovery to marketed use. It
encourages open collaboration by bringing together representatives from
the entire spectrum of the life science landscape and facilitating
crucial discussions across several topic tracks: Clinical Development,
Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy,
and many more.
More info >> |
|
|
|
